Validation of the special projects of national significance adherence tool in HIV/AIDS patients

Annals of Pharmacotherapy

Volumn 44, Issue 6, 2010, Pages 1003-1009

  Julian, Frank S ^a   Martin, Patty ^b   Erickson, Steven R ^c  

^a SINAI GRACE HOSPITAL   (United States)

^b GILEAD SCIENCES   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adherence; AIDS; HIV; SPNS; Survey

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; VALIDATION STUDY; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; VIRAL LOAD; YOUNG ADULT;

EID: 77952938453     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M690     Document Type: Article

References (20)

1. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infections. Ann Intern Med 2000;133:21-30. (Pubitemid 30432540)
2. Gardner EM, Sharma S, Peng G, et al. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS 2008;22:75-82. (Pubitemid 350294880)
3. Shin S, Munoz M, Espiritu B, et al. Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru. J Int Assoc Physicians AIDS Care (Chic Ill) 2008;7:74-81.
4. Nau DP, Aikens J, Pacholski AM. Effects of gender and depression on oral medication adherence in persons with type 2 diabetes mellitus. Gend Med 2007;4:205-213 (Pubitemid 350082736)
5. Carrieri MP, Leport C, Protopopescu C, et al. Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr 2006;41:477-485 (Pubitemid 43756165)
6. Remien RH, Hirky AE, Johnson MO, et al. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav 2003;7:61-72.
7. Trotta MP, Ammassari A, Melzi S, et al. Treatment-related factors and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002;31:S128-31.
8. Heath KV, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS. Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002;31:211-217 (Pubitemid 35190576)
9. Bnesacher BA, Gurwltz JH, Soumeral SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 2007;22:864-871
10. Stone VE, Adelson-Mitty J, Duefield CA, et al. Adherence to protease inhibitors in clinical practice: usefulness of demographics, attitudes, and knowledge as predictors (abstract 32337). Int Conf AIDS 1998;12:588.
11. Ribaudo HJ, Haas DW, Tierney C, et al. Adult AIDS Clinical Trials Group Study. Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study. Clin Infect Dis 2006;42:401-407
12. Torno MS, Witt MD, Saitoh A, Fletcher CV. Successful use of reduced-dose efavirenz in a patient with human immunodeficiency virus infection: case report and review of the literature. Pharmacotherapy 2008;28:782-787 (Pubitemid 351975381)
13. Kalichman SC, Amaral CM, Stearns H, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med 2007;22:1003-1006 (Pubitemid 46878598)
14. Health Resources and Services Administration. HRSA Care Action. http://hab.hrsa.gov/publications/may2005/ (accessed 2008 Oct 12).
15. The assessment of reliability. In: Nunnally JC, Bernstein IH, eds. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994:248-292
16. Glass TR, DeGeest S, Hirschel B, et al. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther 2008;13: 77-85. (Pubitemid 351541676)
17. Mannheimer S, Thackeray L, Huppler Hullsiek K, et al. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care 2008;20:161-169 (Pubitemid 351651267)
18. Wang H, He G, Li X, et al. Self-reported adherence to antiretroviral treatment among HIV-infected people in Central China. AIDS Patient Care STDS 2008;22:71-80.
19. Murri R, Ammassari A, Gallicano K, et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr 2000;24:123-128 (Pubitemid 30640957)
20. Liu H, Miller LG, Hays RD, et al. A comprehensive evaluation of survey questions for adherence to antiretroviral medications and exploratory analyses for identifying optimal sets of survey questions. AIDS Patient Care STDS 2006;20:760-772 (Pubitemid 44904664)